Figure 1.

High ATP1B2 expression is associated with poor prognosis in patients with glioblastoma (GBM). A. ATP1B2 protein expression levels of human tissues from Human Protein Atlas (HPA). B. Immunohistochemical staining for ATP1B2 in GBM tissues (T) and in adjacent non-tumor tissues (N). The GBM tissues with significantly elevated ATP1B2 expression are labeled by asterisks. C. Kaplan-Meier survival analysis of overall survival in TCGA of patients with GBM with ATP1B2 high or low levels, *, P < 0.05.